Kalbe Farma Past Earnings Performance

Past criteria checks 2/6

Kalbe Farma has been growing earnings at an average annual rate of 5.3%, while the Pharmaceuticals industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 8.2% per year. Kalbe Farma's return on equity is 12.1%, and it has net margins of 9.3%.

Key information

5.3%

Earnings growth rate

5.6%

EPS growth rate

Pharmaceuticals Industry Growth20.4%
Revenue growth rate8.2%
Return on equity12.1%
Net Margin9.3%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Kalbe Farma makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

IDX:KLBF Revenue, expenses and earnings (IDR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2430,943,0022,868,5917,612,377327,984
31 Dec 2330,449,1342,766,7487,591,031322,297
30 Sep 2330,312,7382,961,6217,493,610322,723
30 Jun 2330,237,8463,274,2587,311,018339,097
31 Mar 2329,786,9583,403,0457,186,180296,529
31 Dec 2228,933,5033,382,2107,008,307286,805
30 Sep 2228,344,2703,381,4016,989,942297,645
30 Jun 2227,765,3543,323,2857,023,885283,039
31 Mar 2227,261,4853,302,0386,930,882283,381
31 Dec 2126,261,1953,183,6216,800,994285,159
30 Sep 2125,115,5122,993,5916,448,388285,589
30 Jun 2123,878,5702,843,0186,243,097294,376
31 Mar 2123,332,4562,780,4566,182,445287,580
31 Dec 2023,112,6552,733,2606,238,255281,059
30 Sep 2022,902,5072,618,7016,421,524303,010
30 Jun 2023,059,3262,636,1256,466,046292,713
31 Mar 2023,063,5802,580,9626,547,833292,968
31 Dec 1922,633,4762,506,7656,486,989286,655
30 Sep 1922,222,8132,568,1656,314,947253,841
30 Jun 1921,872,4402,499,4306,342,472249,703
31 Mar 1921,424,9102,462,7616,292,038245,288
31 Dec 1821,074,3062,457,1296,243,727237,873
30 Sep 1820,770,5242,428,6306,364,869242,177
30 Jun 1820,496,3452,403,2136,297,021248,906
31 Mar 1820,298,6782,404,7926,240,601238,989
31 Dec 1720,182,1202,403,6066,211,514235,818
30 Sep 1720,087,9792,376,4746,309,736225,629
30 Jun 1719,884,7412,369,7796,270,603208,446
31 Mar 1719,722,8372,324,7506,271,926201,003
31 Dec 1619,374,2312,299,7356,113,081191,713
30 Sep 1619,135,8082,207,6835,992,389184,289
30 Jun 1618,723,4812,087,3325,877,673174,407
31 Mar 1618,190,5142,038,8155,708,469167,739
31 Dec 1517,887,4642,004,2375,664,066163,365
30 Sep 1517,737,8702,078,4875,684,861158,315
30 Jun 1517,708,5582,136,2255,643,279155,102
31 Mar 1517,548,7232,101,5775,531,142147,835
31 Dec 1417,368,5332,066,0225,423,677143,024
30 Sep 1417,320,9062,040,1425,264,833139,464
30 Jun 1416,960,7551,990,4375,144,638139,559
31 Mar 1416,578,6291,968,5495,058,364143,531
31 Dec 1316,002,1311,919,5084,880,697135,388
30 Sep 1315,382,0851,857,4274,663,127124,855
30 Jun 1314,813,5871,848,6144,478,757106,559

Quality Earnings: KLBF has high quality earnings.

Growing Profit Margin: KLBF's current net profit margins (9.3%) are lower than last year (11.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: KLBF's earnings have grown by 5.3% per year over the past 5 years.

Accelerating Growth: KLBF's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: KLBF had negative earnings growth (-15.7%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-10.3%).


Return on Equity

High ROE: KLBF's Return on Equity (12.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.